INFLAMMATORY BREAST CANCER RESEARC… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1999

Legal Domicile

Principal Officer

VIRGINA MASON

Phone

2512816993

Tax Period

2025-01-01 to 2025-12-31

INFLAMMATORY BREAST CANCER RESEARCH FOUNDATION, founded in 1999, is a small nonprofit in the Medical Research sector that reported $128K in total revenue in fiscal year 2025. Revenue surged 102% from the prior year, signaling strong growth momentum. The organization ran a surplus of $107K, a strong 84% operating margin.

Mission

INCREASE PUBLIC AWARENESS AND FACILATE OF IBC PATIENTS AND RESEARCH TOGETHER

Program Service Accomplishments

Program 1

Expenses: $1,500

INCREASING PUBLIC AWARENESS OF IBC PATIENTS AND RESEARCH.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $51,819

Program Service Revenue $0

Investment Income $76,266

Other Revenue $0

TOTAL REVENUE $128,085

Expense Breakdown

Grants Paid $1,500

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $20,885

Other Expenses $19,385

TOTAL EXPENSES $20,885

Year-over-Year Comparison

	2025	2024	Change
Revenue	$128,085	$63,361	+1.0%
Expenses	$20,885	$72,002	-0.7%
Net Income	$107,200	$-8,641	-13.4%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
PHYLLIS JOHNSON	VICE PRESIDENT	5.00	Director	$0	$0	$0
VIRGINA MASON	PRESIDENT	40.00	Officer Director	$0	$0	$0
SHAWN SCOTT	SECRETARY	20.00	Director	$0	$0	$0
DAWN AUBEL	TREASURER	5.00	Director	$0	$0	$0
BRYON DAVIS	MEMBER	5.00	Director	$0	$0	$0
MARY ALPAUGH	MEMBER	5.00	Director	$0	$0	$0
SARAH ZIMOV	MEMBER	5.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$128,085	$20,885	$1,247,891	$107,200
2024	$63,361	$72,002	$1,142,135	$-8,641
2023	$381,094	$38,909	$1,154,301	$342,185
2022	$260,433	$32,327	$807,875	$228,106
2021	$189,670	$24,310	$579,309	$165,360
2020	$74,648	$35,608	$413,949	$39,040

INFLAMMATORY BREAST CANCER RESEARCH FOUNDATION